The Effectiveness of Chinese Medicine Nuan-gong-ye on Primary Dysmenorrhea
NCT ID: NCT06295822
Last Updated: 2024-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
82 participants
INTERVENTIONAL
2024-03-04
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Controlled Trial of Acupuncture for Dysmenorrhea
NCT01116453
A Preliminary Study on the Efficacy of Danggui Shaoyao San and Cuscuta Chinensis in Patients with Primary Dysmenorrhea
NCT06730282
Psychological Outcomes From a Study of Acupuncture Treatment on Experimentally Primary Dysmenorrhea
NCT00689897
Primary Efficacy Evaluation of Traditional Chinese Medicine in Treating Older Infertile Women
NCT03973528
Chinese Herbal Medicine for Gynecologic Patients
NCT06187376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nuan-gong-ye
Nuan-gong-ye
In this study, the ingredients of nuan-gong-ye are myrrh, dragon's blood, yanhu tuber, white mustard seed, asarum root, argy wormwood leaf, holly oil, clove oil, cinnamon bark oil, glycerin, PEG400.
Placebo
Placebo
The placebo was 1/20 concentration of nuan-gong-ye plus glycerin and PEG400.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nuan-gong-ye
In this study, the ingredients of nuan-gong-ye are myrrh, dragon's blood, yanhu tuber, white mustard seed, asarum root, argy wormwood leaf, holly oil, clove oil, cinnamon bark oil, glycerin, PEG400.
Placebo
The placebo was 1/20 concentration of nuan-gong-ye plus glycerin and PEG400.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular menstrual cycle of 21-35 days, with menstruation lasting 3-7 days
* Dysmenorrhea started before the age of 20, and have menstrual pain every month
* No organic lesions on ultrasound within one year (either abdomen or vagina)
* VAS score above 4
* Agree to participate in the study and sign the consent form
Exclusion Criteria
* Allergic to Nuan-gong-ye.
* Has abdominal wounds, infections, or skin diseases.
* Pregnant or planning to become pregnant within the next five months.
* Has taken traditional Chinese medicine or prescribed medication for menstrual pain by a Chinese medicine doctor in the past month.
* Has major illnesses defined by the Taiwan National Health Insurance Administration, such as cancer, heart disease, etc.
* Has mental illness or cognitive impairment and cannot independently fill out the questionnaire.
* Has a history of epilepsy or pelvic disorders.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University Hospital
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMUH112-REC2-063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.